Advanced arc therapy delivery technique further optimized with gold standard planning, helping doctors to provide best possible treatment for patientsAtlanta, GA United States — Thursday, June 10, 2010
Elekta recently announced the latest production release of its Monaco® treatment planning system, version 2.03, which is designed to enhance planning for Elekta VMAT. Monaco provides key features that aid clinicians in planning around structures effectively for Elekta VMAT delivery and accurately predict the total dose the patient will receive.
Monaco helps indicate where clinicians can improve Elekta VMAT plans, according to Rob Cessac, Product Manager, Elekta Software. “By using biological optimization and Monte Carlo dose calculations, Monaco VMAT can help clinicians design timely and accurate treatment plans" he says. “The resulting plans are of similar quality to IMRT, but can be delivered in much less time, enabling a more efficient clinic and a better patient experience."
In advance of the full launch of Monaco 2.03, sites in Asia, Central America, Europe and the United States have clinically implemented the planning system for Elekta VMAT delivery.
For additional information, visit www.elekta.com/monacovmat.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37
Time zone: CET: Central European Time
Michelle Lee Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447
Time zone: ET: Eastern Time